Cargando…
Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy
[Image: see text] Pancreatic cancer (PanCa) is a highly lethal disease with a poor 5 year survival rate, less than 7%. It has a dismal prognosis, and more than 50% of cases are detected at an advanced and metastatic stage. Gemcitabine (GEM) is a gold standard chemotherapy used for PanCa treatment. H...
Autores principales: | Shetty, Advait, Nagesh, Prashanth K.B., Setua, Saini, Hafeez, Bilal B., Jaggi, Meena, Yallapu, Murali M., Chauhan, Subhash C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178800/ https://www.ncbi.nlm.nih.gov/pubmed/32337462 http://dx.doi.org/10.1021/acsomega.0c00793 |
Ejemplares similares
-
Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer
por: Chowdhury, Pallabita, et al.
Publicado: (2018) -
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019) -
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
por: Nagesh, Prashanth K. B., et al.
Publicado: (2018) -
Biomolecule-functionalized nanoformulations for prostate cancer theranostics
por: Pranav, et al.
Publicado: (2022) -
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes
por: Yallapu, Murali Mohan, et al.
Publicado: (2011)